...
首页> 外文期刊>Histochemistry and cell biology >Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).
【24h】

Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).

机译:紫杉醇和长春瑞滨在人肺腺癌细胞(A-549)中引起细胞凋亡的协同增加,但不会引起微管破坏的协同增加。

获取原文
获取原文并翻译 | 示例
           

摘要

Concurrent administration of paclitaxel and vinorelbine results in cytotoxicity in vivo and in vitro in a number of tumor cell lines, yet the mechanisms of enhanced cell killing are undefined. In studies here, we show that low concentrations (1 nM) of paclitaxel and vinorelbine in combination result in enhanced cell killing by apoptosis ( P<0.05) in the human lung adenocarcinoma cell line, A-549. In contrast, necrotic cell death and formation of multinucleated cells, which were significantly increased by paclitaxel ( P<0.05) alone, but not vinorelbine, were not increased synergistically by both drugs. Paclitaxel also caused microtubular disruption which was not observed with vinorelbine. These data provide further rationale for the combined use of paclitaxel and vinorelbine in clinical trials, and suggest that the cooperative effects of drugs on apoptosis are not mediated through similar disruptional effects on microtubules.
机译:紫杉醇和长春瑞滨同时给药会在许多肿瘤细胞系中体内和体外产生细胞毒性,但增强细胞杀伤的机制尚不清楚。在这里的研究中,我们显示了低浓度(1 nM)的紫杉醇和长春瑞滨的组合会导致人肺腺癌细胞系A-549中细胞凋亡的杀伤作用增强(P <0.05)。相比之下,单独使用紫杉醇显着增加了坏死细胞死亡和多核细胞的形成(P <0.05),但长春瑞滨则没有,但两种药物均未协同增加坏死细胞的死亡和多核细胞的形成。紫杉醇还引起微管破裂,长春瑞滨则未观察到。这些数据为紫杉醇和长春瑞滨在临床试验中的联合使用提供了进一步的理论依据,并表明药物对细胞凋亡的协同作用并未通过对微管的类似破坏作用来介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号